Completed
Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial
NCT01372644
- Conditions
- Adenocarcinoma, Atypical Ductal Breast Hyperplasia, Atypical Lobular Hyperplasia (ALH) of Breast, +14 more
- Locations
-
- NYU School of Medicine New York, United States